EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSFOG00015023448
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSSFOG00015015234
Gene Symbol: LOC108931696
3 Cross references
205 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSSFOG00015019284
Gene Symbol: LOC108923404
3 Cross references
191 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSSFOG00015010140
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSFOG00015017470
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSSFOG00015010593
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSFOG00015031652
Gene Symbol: KIF5B
3 Cross references
148 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSFOG00015005922
Gene Symbol: KIF5B
3 Cross references
138 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSSFOG00015012722
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSSFOG00015023940
Gene Symbol: LTA4H
3 Cross references
139 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSFOG00015012597
Gene Symbol: LOC108941282
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSFOG00015012493
Gene Symbol: LOC108937879
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).